Quantcast
Last updated on April 18, 2014 at 12:27 EDT

Latest Venous ulcer Stories

2014-04-07 08:30:21

ADDISON, Texas, April 7, 2014 /PRNewswire/ --ULURU Inc. (OTCQB: ULUR), is pleased to provide an update on the pharmacoeconomic analysis being conducted in Europe on Altrazeal(®), the Company's innovative wound dressing. The purpose of this pharmacoeconomic analysis is to evaluate both the cost and healing benefits of Altrazeal(®) when compared to conventional dressings and advanced moist wound healing products. The analysis is being conducted on defined-wound types and sizes,...

2014-03-27 12:31:18

VIRGINIA BEACH, Va., March 27, 2014 /PRNewswire-USNewswire/ -- Recent healthcare coverage decisions could offer relief to the nearly twelve million Medicare-eligible Seniors across 15 States, based on estimates from the Centers for Medicare & Medicaid. Senior citizens with diabetes are at risk to develop diabetic foot ulcers and venous leg ulcers - hard-to-heal wounds that are involved in nearly two-thirds of all non-traumatic lower limb amputations each year. Novitas, a Part A...

2014-02-23 23:00:50

Transparency Market Research Report added "Global Negative Pressure Wound Therapy Market - Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" to its database. Browse full report: http://www.transparencymarketresearch.com/negative-pressure-wound-therapy.html. Albany, New York, USA (PRWEB) February 23, 2014 Negative Pressure Wound Therapy (NPWT) also known as Vacuum Assisted Closure (V.A.C) is a wound dressing technique that aids in healing acute and chronic...

2014-02-06 23:02:45

Journey below the skin's surface for a better understanding of leg health and venous disorders with SIGVARIS’ new educational app for iPad. Peachtree City, GA (PRWEB) February 06, 2014 Physicians who advise patients about their leg health now have a new tool at their fingertips. SIGVARIS’ new app goes beneath the skin's surface to help explain the circulatory system and leg health conditions to patients in an illustrative way that is easy to understand. Traveling deep into...

2014-01-13 08:29:02

COLUMBIA, Md., Jan. 13, 2014 /PRNewswire/ -- ACell, Inc., a leading regenerative medicine company focused on the development, manufacturing and commercialization of tissue repair products, today announced it has initiated, with multiple patients enrolled, a U.S. post-market clinical trial (NCT01858545) comparing the efficacy of MatriStem® to a leading cellular scaffold, Dermagraft®, for the treatment of patients with diabetic foot ulcers (DFUs) that failed to adequately heal...

2013-12-11 08:24:09

-Exclusive Agreement signed for Italy, Spain and Greece- ADDISON, Texas, Dec. 11, 2013 /PRNewswire/ -- ULURU Inc. (OTCQB: ULUR), today announced the expansion of the Altrazeal(®) international marketing network. Agreements have been signed granting the exclusive marketing and distribution rights for Altrazeal(®) in Italy, Spain and Greece. Commenting on the extension of the international marketing network, Helmut Kerschbaumer, Managing Director of Altrazeal GmbH, stated, "These...

2013-11-25 16:26:59

DUBLIN, November 25, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/tk86qz/global_wound) has announced the addition of the "Global Wound Dressing Market 2012-2016" [http://www.researchandmarkets.com/research/tk86qz/global_wound ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) One of the key factors contributing to this market growth is the increase in the aging population. The Global...

2013-11-19 12:30:05

Follow Up Study Accepted For Publication In Wound Medicine MARIETTA, Ga., Nov. 19, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that its study "Dehydrated Human Amnion/Chorion Membrane Allografts in Patients with Chronic Diabetic Foot Ulcers: A Long-term Follow-up Study" has been accepted for publication...

2013-11-08 08:28:28

SAN DIEGO, Nov. 8, 2013 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today announced the publication of a case study, "Serial Sharp Debridement and Formulated Collagen Gel to Treat Pressure Ulcers in Elderly Long-term Care Patients", in the peer-reviewed November 2013 issue of Ostomy Wound Management Ostomy Wound Manage. 2013;59(11):43-49. The electronic publication of the study is available at...

2013-10-03 09:26:15

Researchers from Université Laval's Faculty of Medicine and CHU de Québec have shown that it is possible to treat venous ulcers unresponsive to conventional treatment with wound dressings made from human skin grown in vitro. A study published recently in the journal Advances in Skin and Wound Care demonstrates how this approach was successfully used to treat venous lower-extremity ulcers in patients who had been chronically suffering from such wounds. About 1% of the population suffers...